Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/02/21
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2021 Financial Results and Recent Business HighlightsGlobeNewsWire • 08/16/21
Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10Benzinga • 07/26/21
Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving TodayBenzinga • 04/26/21
Reviva's stock jumps after experimental schizophrenia drug meets endpoint in Phase 2 clinical trialMarket Watch • 04/26/21
Reviva Pharma Stock Trading Higher On Detailed Positive Schizophrenia Study ResultsBenzinga • 04/26/21
Reviva Announces Full Details of Positive Phase 2 Clinical Trial Results for Acute SchizophreniaGlobeNewsWire • 04/26/21
Reviva Pharmaceuticals Holdings, Inc. Reports 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/22/21